hotspot -WSS

hotspot

author：entertainment 2025-09-30 17:44:01 - browse：5

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Gene therapy for Afghan refugees’ infant will be fully covered

WSS

The battle over the Brookhaven Landfill on Long Island

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Top private equity targets in 2023: cardiology, clinical trials, lasers

Top private equity targets in 2023: cardiology, clinical trials, lasers

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Do masks work? RCTs can't tell us

entertainment

hotspot

focus

Jerome Adams on the need for new antivirals for Covid

Why Novartis is going to walk from its acquisition of MorphoSys

At least 13 dead in Texas as scorching temps continue

A protest over insulin prices is seen as a fight for life

Sports medicine is finally prioritizing gender equality

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Devoted Health’s losses in Medicare Advantage persist

Peter Hotez and the public health issue of online harassment

Disclosing genetic information: not as worrisome as once feared

leisure time

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Gene therapy has helped boys walk. Can scientists keep it that way?

The story of mRNA: From a loose idea to a tool that may help curb Covid

Global cancer cases to surge 77% by 2050, WHO report says

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

The battle over the Brookhaven Landfill on Long Island

hotspot

leisure time

Wikipedia